BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

204 related articles for article (PubMed ID: 23594375)

  • 1. Bisphosphonate use and risk of colorectal cancer: a systematic review and meta-analysis.
    Bonovas S; Nikolopoulos G; Bagos P
    Br J Clin Pharmacol; 2013 Sep; 76(3):329-37. PubMed ID: 23594375
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Exposure to bisphosphonates and risk of colorectal cancer.
    Ma J; Gao S; Ni X; Chen F; Liu X; Xie H; Yin H; Lu C
    Br J Clin Pharmacol; 2013 Sep; 76(3):320-8. PubMed ID: 23451731
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Bisphosphonate use and gastrointestinal tract cancer risk: meta-analysis of observational studies.
    Oh YH; Yoon C; Park SM
    World J Gastroenterol; 2012 Oct; 18(40):5779-88. PubMed ID: 23155320
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Statins and the risk of colorectal cancer: a meta-analysis of 18 studies involving more than 1.5 million patients.
    Bonovas S; Filioussi K; Flordellis CS; Sitaras NM
    J Clin Oncol; 2007 Aug; 25(23):3462-8. PubMed ID: 17687150
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Oral bisphosphonates and the risk of colorectal cancer: a meta-analysis.
    Yang G; Hu H; Zeng R; Huang J
    J Clin Gastroenterol; 2013 Oct; 47(9):741-8. PubMed ID: 24030705
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Bisphosphonates are associated with reduced risk of colorectal cancer: a systematic review and meta-analysis.
    Singh S; Singh AG; Murad MH; Limburg PJ
    Clin Gastroenterol Hepatol; 2013 Mar; 11(3):232-9.e1. PubMed ID: 23220165
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Calcium supplementation for the prevention of colorectal adenomas: A systematic review and meta-analysis of randomized controlled trials.
    Bonovas S; Fiorino G; Lytras T; Malesci A; Danese S
    World J Gastroenterol; 2016 May; 22(18):4594-603. PubMed ID: 27182169
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Paracetamol use and risk of ovarian cancer: a meta-analysis.
    Bonovas S; Filioussi K; Sitaras NM
    Br J Clin Pharmacol; 2006 Jul; 62(1):113-21. PubMed ID: 16842383
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Systematic review with meta-analysis: use of 5-aminosalicylates and risk of colorectal neoplasia in patients with inflammatory bowel disease.
    Bonovas S; Fiorino G; Lytras T; Nikolopoulos G; Peyrin-Biroulet L; Danese S
    Aliment Pharmacol Ther; 2017 May; 45(9):1179-1192. PubMed ID: 28261835
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Reduced risk of colorectal cancer with use of oral bisphosphonates: a systematic review and meta-analysis.
    Thosani N; Thosani SN; Kumar S; Nugent Z; Jimenez C; Singh H; Guha S
    J Clin Oncol; 2013 Feb; 31(5):623-30. PubMed ID: 23269990
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Bisphosphonates for breast cancer.
    Pavlakis N; Schmidt R; Stockler M
    Cochrane Database Syst Rev; 2005 Jul; (3):CD003474. PubMed ID: 16034900
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Statins and the risk of colorectal cancer: an updated systematic review and meta-analysis of 40 studies.
    Lytras T; Nikolopoulos G; Bonovas S
    World J Gastroenterol; 2014 Feb; 20(7):1858-70. PubMed ID: 24587664
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Bisphosphonates and risk of cancers: a systematic review and meta-analysis.
    Li YY; Gao LJ; Zhang YX; Liu SJ; Cheng S; Liu YP; Jia CX
    Br J Cancer; 2020 Nov; 123(10):1570-1581. PubMed ID: 32901134
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Phyto-oestrogens and colorectal cancer risk: a systematic review and dose-response meta-analysis of observational studies.
    Jiang R; Botma A; Rudolph A; Hüsing A; Chang-Claude J
    Br J Nutr; 2016 Dec; 116(12):2115-2128. PubMed ID: 28091359
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Bisphosphonates for breast cancer.
    Pavlakis N; Stockler M
    Cochrane Database Syst Rev; 2002; (1):CD003474. PubMed ID: 11869664
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Bisphosphonate use and the risk of breast cancer: a meta-analysis of observational studies.
    Ou YJ; Chiu HF; Wong YH; Yang CC; Yang YH
    Pharmacoepidemiol Drug Saf; 2017 Oct; 26(10):1286-1295. PubMed ID: 28857419
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Bisphosphonates in multiple myeloma: a network meta-analysis.
    Mhaskar R; Redzepovic J; Wheatley K; Clark OA; Miladinovic B; Glasmacher A; Kumar A; Djulbegovic B
    Cochrane Database Syst Rev; 2012 May; (5):CD003188. PubMed ID: 22592688
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Use of statins and breast cancer: a meta-analysis of seven randomized clinical trials and nine observational studies.
    Bonovas S; Filioussi K; Tsavaris N; Sitaras NM
    J Clin Oncol; 2005 Dec; 23(34):8606-12. PubMed ID: 16260694
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Bisphosphonates for osteoporosis in primary biliary cirrhosis.
    Rudic JS; Giljaca V; Krstic MN; Bjelakovic G; Gluud C
    Cochrane Database Syst Rev; 2011 Dec; (12):CD009144. PubMed ID: 22161446
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 11.